Current schizophrenia medications treat symptoms such as hallucinations and delusions, but do little for cognitive symptoms ...

Researchers say discovery could establish the basis for a novel, tandem biomarker-peptide therapeutic approach to schizophrenia.

New Assay Expands INDIGO’s GPCR Portfolio and Supports Development of Next-Generation CNS-Related Therapeutics STATE ...

Current schizophrenia medications treat symptoms such as hallucinations and delusions, but do little for cognitive symptoms like disorganized thinking or executive dysfunction. As a result, many ...

Scientists at Arc Institute and Stanford University have discovered that age-related memory loss may be driven by changes in the gut rather than the brain itself. In a study published in Nature, ...

Sleep disorders are associated with greater cognitive impairment and poorer instrumental activities of daily living in patients with AD.

Pituitary neuroendocrine tumors (PitNETs) are commonly associated with visual disturbances and endocrine abnormalities; however, many patients also experience cognitive deficits, particularly in ...

A Gerontological Society of America (GSA) report summarizes survey findings on the readiness of the primary care workforce to adopt digital cognitive assessments (DCAs) for use in the diagnostic ...

Early autonomic dysfunction in prodromal Parkinson disease independently predicts a substantially higher risk for earlier cognitive impairment, suggesting autonomic assessment may help identify ...

Autonomic dysfunction affected 63% of patients with early-onset Parkinson’s disease (EOPD) and was associated with a threefold higher risk for mortality in a new cohort study. Each additional ...

Veterinary experts establish new guidelines for diagnosing and monitoring CCDS. A group of researchers from across the globe have released a set of guidelines veterinary professionals can use when ...